AtriCure Inc - Asset Resilience Ratio
AtriCure Inc (ATRC) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check ATRC capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2024)
This chart shows how AtriCure Inc's Asset Resilience Ratio has changed over time. See debt-free asset ratio of AtriCure Inc to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down AtriCure Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ATRC market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: AtriCure Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
AtriCure Inc Industry Peers by Asset Resilience Ratio
Compare AtriCure Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
AVE Science & Technology Co Ltd
SHG:688067 |
Medical Instruments & Supplies | 24.13% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.29% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
Annual Asset Resilience Ratio for AtriCure Inc (2005–2024)
The table below shows the annual Asset Resilience Ratio data for AtriCure Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.00% | $0.00 | $609.33 Million | -- |
| 2023-12-31 | 8.63% | $52.98 Million | $613.93 Million | -2.13pp |
| 2022-12-31 | 10.76% | $63.01 Million | $585.45 Million | -1.50pp |
| 2021-12-31 | 12.26% | $75.44 Million | $615.31 Million | -16.05pp |
| 2020-12-31 | 28.31% | $202.27 Million | $714.54 Million | +18.75pp |
| 2019-12-31 | 9.56% | $53.32 Million | $557.88 Million | -16.28pp |
| 2018-12-31 | 25.84% | $92.17 Million | $356.76 Million | +21.11pp |
| 2017-12-31 | 4.72% | $12.64 Million | $267.70 Million | -2.44pp |
| 2016-12-31 | 7.16% | $19.80 Million | $276.42 Million | +3.20pp |
| 2015-12-31 | 3.96% | $10.81 Million | $273.09 Million | -15.78pp |
| 2014-12-31 | 19.74% | $31.27 Million | $158.40 Million | +9.63pp |
| 2013-12-31 | 10.11% | $11.32 Million | $111.95 Million | -2.98pp |
| 2012-12-31 | 13.10% | $4.25 Million | $32.43 Million | +0.03pp |
| 2011-12-31 | 13.07% | $4.42 Million | $33.86 Million | -11.67pp |
| 2010-12-31 | 24.74% | $8.34 Million | $33.72 Million | +5.25pp |
| 2009-12-31 | 19.49% | $6.82 Million | $34.98 Million | +4.28pp |
| 2007-12-31 | 15.21% | $7.01 Million | $46.07 Million | +3.46pp |
| 2006-12-31 | 11.75% | $4.60 Million | $39.13 Million | -0.98pp |
| 2005-12-31 | 12.73% | $6.37 Million | $50.04 Million | -- |
About AtriCure Inc
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; m… Read more